Esomeprazole- or rabeprazole-based triple therapy eradicated Helicobacter pylori comparably regardless of clarithromycin susceptibility and CYP2C19 genotypes
The aim of this study was to assess the efficacy of esomeprazole-based triple therapy compared with rabeprazole-based triple therapy according to CYP2C19 genotype and clarithromycin susceptibility status for first-line eradication therapy of Helicobacter pylori (H. pylori) in Japan. We enrolled 219...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
the Society for Free Radical Research Japan
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018575/ |